Breanna J. Sheahan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Breanna J. Sheahan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Christopher M. Dekaney
Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina
3 shared publications - Lillian M. B. Haywood
Department of Clinical Sciences, College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA
2 shared publications Adrian J. McNairn
Cornell University, College of Veterinary Medicine
1 shared publication- Ajeet Pratap Singh
Affiliation American Type Culture Collection (ATCC), Manassas, Virginia, United States of America
1 shared publication - Alessandro Bonfini
Department of Colorectal Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, PR China.
1 shared publication - Alexandra S. Fielding
Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 264 (10) , 1-8
Retrospective endoscopic assessment of complications associated with nasogastric intubation in horses at a referral hospital
Objective: To characterize the incidence of complications confirmed via endoscopy following nasogastric intubation in horses at a referral institution and determine associated risk factors. Methods: Medical records of patients having received ≥ 1 nasogastric intubation within 3 days prior to endoscopic examination between March 2021 and March 2025 were identified. Signalment, history, clinicopathologic data, nasogastric intubation procedures, reason for endoscopy, treatment, and outcome were recorded. Complications were categorized by region (nasopharyngeal, esophageal, gastric). Clinical complications were defined as those prompting endoscopic examination, whereas subclinical complications were observed incidentally during endoscopy performed for other reasons. Results: 94 cases met the inclusion criteria. Of these, 25 of 94 (26.6%) had a complication observed on endoscopy, with the majority (68%) being subclinical. Horses with nasopharyngeal complications were the most likely to have clinical signs (60%), followed by those with esophageal complications (33%) and gastric complications (0%). Horses with complications had lower body weights (median, 430 kg; 95% CI, 365 to 482 kg) and increased numbers of band neutrophils than those without complications (median, 518 kg; 95% CI, 486 to 548 kg). Intubation prior to referral, number of intubations performed, and presence of an indwelling tube were not associated with complications. Conclusions: Subclinical complications after nasogastric intubation occurred in a quarter of endoscopically examined cases not exposed to general anesthesia. Clinical complications were uncommon. Smaller horses may be more at risk for subclinical complications. Clinical Relevance: Clinical complications are uncommon after routine nasogastric intubation; however, endoscopy after nasogastric intubation may identify incidental subclinical complications.
- 1 October 2026
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 264 (10) , 1-8
Open AccessRetrospective endoscopic assessment of complications associated with nasogastric intubation in horses at a referral hospital
Objective: To characterize the incidence of complications confirmed via endoscopy following nasogastric intubation in horses at a referral institution and determine associated risk factors. Methods: Medical records of patients having received ≥ 1 nasogastric intubation within 3 days prior to endoscopic examination between March 2021 and March 2025 were identified. Signalment, history, clinicopathologic data, nasogastric intubation procedures, reason for endoscopy, treatment, and outcome were recorded. Complications were categorized by region (nasopharyngeal, esophageal, gastric). Clinical complications were defined as those prompting endoscopic examination, whereas subclinical complications were observed incidentally during endoscopy performed for other reasons. Results: 94 cases met the inclusion criteria. Of these, 25 of 94 (26.6%) had a complication observed on endoscopy, with the majority (68%) being subclinical. Horses with nasopharyngeal complications were the most likely to have clinical signs (60%), followed by those with esophageal complications (33%) and gastric complications (0%). Horses with complications had lower body weights (median, 430 kg; 95% CI, 365 to 482 kg) and increased numbers of band neutrophils than those without complications (median, 518 kg; 95% CI, 486 to 548 kg). Intubation prior to referral, number of intubations performed, and presence of an indwelling tube were not associated with complications. Conclusions: Subclinical complications after nasogastric intubation occurred in a quarter of endoscopically examined cases not exposed to general anesthesia. Clinical complications were uncommon. Smaller horses may be more at risk for subclinical complications. Clinical Relevance: Clinical complications are uncommon after routine nasogastric intubation; however, endoscopy after nasogastric intubation may identify incidental subclinical complications.
- 15 September 2026
- Published by Wiley in Equine Veterinary Journal
Use of a caudal intercostal block in horses undergoing surgery for colic
Background: In humans and companion animals, regional anaesthesia is used in multimodal analgesic protocols for abdominal wall surgery. Benefits include earlier patient mobilisation and improved pain scores. Regional anaesthetic techniques for horses undergoing abdominal surgery could provide similar benefits and warrant investigation. Objectives: To evaluate the safety and efficacy of a caudal intercostal block for abdominal surgery (CIBAS) in horses undergoing surgery for colic. Study Design: Blinded, randomised clinical trial. Methods: Horses ( n = 22) undergoing exploratory celiotomy for colic were randomly assigned to receive CIBAS (1 mg/kg bupivacaine, 1 μg/kg epinephrine and 1 μg/kg dexmedetomidine), or an equivalent volume of saline (control). Recovery quality was assessed by blinded personnel using a semi‐quantitative rubric. Pain scores for the first 24‐h postoperatively were assigned by blinded observers trained to use validated composite visceral and facial pain scales. A Chi‐square test for trend was used to compare recovery scores between groups, and an unpaired t ‐test was used to compare the area under the curve (AUC 0–24h ) for composite pain scores between groups. Results: Horses receiving CIBAS had significantly better recovery scores than those in the saline group (median 3, IQR [3, 4] p = 0.05). CIBAS horses also had significantly lower AUC 0–24h pain scores (243.9; 95% CI [172.1, 315.8]) than horses receiving saline (331.1; 95% CI [233.9, 428.4] p = 0.0002). Main Limitations: Unstandardised anaesthetic protocols, use of a semiquantitative recovery score, CIBAS not tested for efficacy, and small sample size. Conclusions: CIBAS is safe to perform. Horses that received CIBAS had significantly better recovery scores and significantly lower pain scores over the first 24‐h postoperatively, compared to horses that received saline. Supplies to perform the block are inexpensive and accessible to most clinicians. CIBAS can be considered a safe option in horses undergoing exploratory celiotomy.
- 15 September 2026
- Published by Wiley in Equine Veterinary Journal
Use of a caudal intercostal block in horses undergoing surgery for colic
Background: In humans and companion animals, regional anaesthesia is used in multimodal analgesic protocols for abdominal wall surgery. Benefits include earlier patient mobilisation and improved pain scores. Regional anaesthetic techniques for horses undergoing abdominal surgery could provide similar benefits and warrant investigation. Objectives: To evaluate the safety and efficacy of a caudal intercostal block for abdominal surgery (CIBAS) in horses undergoing surgery for colic. Study Design: Blinded, randomised clinical trial. Methods: Horses ( n = 22) undergoing exploratory celiotomy for colic were randomly assigned to receive CIBAS (1 mg/kg bupivacaine, 1 μg/kg epinephrine and 1 μg/kg dexmedetomidine), or an equivalent volume of saline (control). Recovery quality was assessed by blinded personnel using a semi‐quantitative rubric. Pain scores for the first 24‐h postoperatively were assigned by blinded observers trained to use validated composite visceral and facial pain scales. A Chi‐square test for trend was used to compare recovery scores between groups, and an unpaired t ‐test was used to compare the area under the curve (AUC 0–24h ) for composite pain scores between groups. Results: Horses receiving CIBAS had significantly better recovery scores than those in the saline group (median 3, IQR [3, 4] p = 0.05). CIBAS horses also had significantly lower AUC 0–24h pain scores (243.9; 95% CI [172.1, 315.8]) than horses receiving saline (331.1; 95% CI [233.9, 428.4] p = 0.0002). Main Limitations: Unstandardised anaesthetic protocols, use of a semiquantitative recovery score, CIBAS not tested for efficacy, and small sample size. Conclusions: CIBAS is safe to perform. Horses that received CIBAS had significantly better recovery scores and significantly lower pain scores over the first 24‐h postoperatively, compared to horses that received saline. Supplies to perform the block are inexpensive and accessible to most clinicians. CIBAS can be considered a safe option in horses undergoing exploratory celiotomy.
- Open Access
- 23 April 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 163, 105916
Downregulation of a choline transporter gene in equine colitis indicates a role for choline supplementation to support the large intestinal epithelial barrier
- 23 April 2026
- Published by Elsevier in Journal of Equine Veterinary Science
- Vol. 163, 105916
Open AccessDownregulation of a choline transporter gene in equine colitis indicates a role for choline supplementation to support the large intestinal epithelial barrier
- Open Access
- 14 November 2025
- Published by Wiley in Equine Veterinary Journal
- Vol. 58 (2) , 414-422
A novel kirkovirus may be associated with equine gastrointestinal disease
Background: Many cases of equine enterocolitis are suspected to be infectious in nature, but no pathogen is identified in many cases. Objectives: Perform next‐generation sequencing on faeces collected from cases of equine enterocolitis for the presence of novel viruses and determine if an identified novel virus is associated with cases of equine enterocolitis. Study Design: Retrospective cohort study. Methods: Next generation sequencing was performed targeting viral genomes from n = 13 pooled faecal samples ( n = 5 horses/pool) with enterocolitis. Subsequent qPCR was performed targeting the highly conserved replication‐associated segment of the identified kirkovirus genome on n = 218 samples (collected between 2020 and 2025), divided into 3 groups [colitis ( n = 87), colic ( n = 56) and clinically normal ( n = 75)]. Additional qPCR was performed on a subset of cases targeting the less well‐conserved open reading frame 3 (ORF3) segment of the kirkovirus genome. In situ hybridisation and electron microscopy on kirkovirus‐positive samples were also performed. Results: Next generation sequencing identified a novel kirkovirus in 5/13 pooled samples from enterocolitis cases, including the full genome. There was an association between the novel kirkovirus and enterocolitis, specifically in two farm outbreaks. A retrospective case review of kirkovirus‐positive cases suggested a seasonal pattern, with all cases presented in the autumn, winter, and spring. Additionally, there was an association with small colon impactions, with 25% of positive cases having a small colon impaction. Main Limitations: Whether equine kirkovirus is a cause of equine infectious enterocolitis remains unknown. There are limited available tissue samples from positive horses and efforts to definitively identify equine kirkovirus in the gastrointestinal tract tissues have been unsuccessful. Conclusions: We identified a novel equine kirkovirus that is associated with outbreaks of enterocolitis and small colon impactions. It is rarely identified in clinically normal populations. Further study must be performed to determine if the virus infects equine tissues and/or causes disease.
- 14 November 2025
- Published by Wiley in Equine Veterinary Journal
- Vol. 58 (2) , 414-422
Open AccessA novel kirkovirus may be associated with equine gastrointestinal disease
Background: Many cases of equine enterocolitis are suspected to be infectious in nature, but no pathogen is identified in many cases. Objectives: Perform next‐generation sequencing on faeces collected from cases of equine enterocolitis for the presence of novel viruses and determine if an identified novel virus is associated with cases of equine enterocolitis. Study Design: Retrospective cohort study. Methods: Next generation sequencing was performed targeting viral genomes from n = 13 pooled faecal samples ( n = 5 horses/pool) with enterocolitis. Subsequent qPCR was performed targeting the highly conserved replication‐associated segment of the identified kirkovirus genome on n = 218 samples (collected between 2020 and 2025), divided into 3 groups [colitis ( n = 87), colic ( n = 56) and clinically normal ( n = 75)]. Additional qPCR was performed on a subset of cases targeting the less well‐conserved open reading frame 3 (ORF3) segment of the kirkovirus genome. In situ hybridisation and electron microscopy on kirkovirus‐positive samples were also performed. Results: Next generation sequencing identified a novel kirkovirus in 5/13 pooled samples from enterocolitis cases, including the full genome. There was an association between the novel kirkovirus and enterocolitis, specifically in two farm outbreaks. A retrospective case review of kirkovirus‐positive cases suggested a seasonal pattern, with all cases presented in the autumn, winter, and spring. Additionally, there was an association with small colon impactions, with 25% of positive cases having a small colon impaction. Main Limitations: Whether equine kirkovirus is a cause of equine infectious enterocolitis remains unknown. There are limited available tissue samples from positive horses and efforts to definitively identify equine kirkovirus in the gastrointestinal tract tissues have been unsuccessful. Conclusions: We identified a novel equine kirkovirus that is associated with outbreaks of enterocolitis and small colon impactions. It is rarely identified in clinically normal populations. Further study must be performed to determine if the virus infects equine tissues and/or causes disease.
- Open Access
- 24 February 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12, 1512343
Equine neutrophils selectively release neutrophil extracellular traps in response to chemical and bacterial agonists
Introduction: Neutrophil extracellular traps (NETs) play a significant role in response to a variety of infectious and inflammatory stimuli in human and veterinary medicine. Although entrapment of bacteria can be an important function of NETs, the exuberant release of DNA and other intracellular molecules has also been negatively implicated in the pathogenesis of different diseases. Thus, NET formation must be tightly controlled and represents an opportunity for therapeutic interventions. Horses are particularly sensitive to bacterial stimuli that have previously been shown to cause NETs in other species, but the species-specific processes that control NET release have not been fully elucidated.Methods: The purpose of this study was to compare the magnitude of response of equine neutrophils to different chemical and bacterial stimuli, including phorbol 12-myristate 13-acetate (PMA), a calcium ionophore (A23187), Staphylococcus aureus, and Escherichia coli. In addition, we investigated whether ex vivo equine NET formation is controlled by the NADPH-oxidase (NOX) pathway and by autophagy, both of which control NET formation in other species.Results: We demonstrated that equine neutrophils produce robust NETs in response to calcium ionophore and E. coli stimuli and produce fewer NETs in response to PMA and S. aureus. Both NOX-dependent and NOX-independent pathways of NET formation were identified in equine neutrophils. Autophagy inhibition altered the mechanics of NET release, by reducing the amount of extracellular DNA stranding.Discussion: These results provide insight into equine-specific neutrophil biology, which could be key for managing equine diseases such as asthma and laminitis.
- 24 February 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12, 1512343
Open AccessEquine neutrophils selectively release neutrophil extracellular traps in response to chemical and bacterial agonists
Introduction: Neutrophil extracellular traps (NETs) play a significant role in response to a variety of infectious and inflammatory stimuli in human and veterinary medicine. Although entrapment of bacteria can be an important function of NETs, the exuberant release of DNA and other intracellular molecules has also been negatively implicated in the pathogenesis of different diseases. Thus, NET formation must be tightly controlled and represents an opportunity for therapeutic interventions. Horses are particularly sensitive to bacterial stimuli that have previously been shown to cause NETs in other species, but the species-specific processes that control NET release have not been fully elucidated.Methods: The purpose of this study was to compare the magnitude of response of equine neutrophils to different chemical and bacterial stimuli, including phorbol 12-myristate 13-acetate (PMA), a calcium ionophore (A23187), Staphylococcus aureus, and Escherichia coli. In addition, we investigated whether ex vivo equine NET formation is controlled by the NADPH-oxidase (NOX) pathway and by autophagy, both of which control NET formation in other species.Results: We demonstrated that equine neutrophils produce robust NETs in response to calcium ionophore and E. coli stimuli and produce fewer NETs in response to PMA and S. aureus. Both NOX-dependent and NOX-independent pathways of NET formation were identified in equine neutrophils. Autophagy inhibition altered the mechanics of NET release, by reducing the amount of extracellular DNA stranding.Discussion: These results provide insight into equine-specific neutrophil biology, which could be key for managing equine diseases such as asthma and laminitis.
- Open Access
- 7 October 2024
- Published by MDPI AG in Veterinary Sciences
- Vol. 11 (10) , 480
A Review of Epithelial Ion Transporters and Their Roles in Equine Infectious Colitis
Equine colitis is a devastating disease with a high mortality rate. Infectious pathogens associated with colitis in the adult horse include Clostridioides difficile, Clostridium perfringens, Salmonella spp., Neorickettsia risticii/findlaynesis, and equine coronavirus. Antimicrobial-associated colitis can be associated with the presence of infectious pathogens. Colitis can also be due to non-infectious causes, including non-steroidal anti-inflammatory drug administration, sand ingestion, and infiltrative bowel disease. Current treatments focus on symptomatic treatment (restoring fluid and electrolyte balance, preventing laminitis and sepsis). Intestinal epithelial ion channels are key regulators of electrolyte (especially sodium and chloride) and water movement into the lumen. Dysfunctional ion channels play a key role in the development of diarrhea. Infectious pathogens, including Salmonella spp. and C. difficile, have been shown to regulate ion channels in a variety of ways. In other species, there has been an increased interest in ion channel manipulation as an anti-diarrheal treatment. While targeting ion channels also represents a promising way to manage diarrhea associated with equine colitis, ion channels have not been well studied in the equine colon. This review provides an overview of what is known about colonic ion channels and their known or putative role in specific types of equine colitis due to various pathogens.
- 7 October 2024
- Published by MDPI AG in Veterinary Sciences
- Vol. 11 (10) , 480
Open AccessA Review of Epithelial Ion Transporters and Their Roles in Equine Infectious Colitis
Equine colitis is a devastating disease with a high mortality rate. Infectious pathogens associated with colitis in the adult horse include Clostridioides difficile, Clostridium perfringens, Salmonella spp., Neorickettsia risticii/findlaynesis, and equine coronavirus. Antimicrobial-associated colitis can be associated with the presence of infectious pathogens. Colitis can also be due to non-infectious causes, including non-steroidal anti-inflammatory drug administration, sand ingestion, and infiltrative bowel disease. Current treatments focus on symptomatic treatment (restoring fluid and electrolyte balance, preventing laminitis and sepsis). Intestinal epithelial ion channels are key regulators of electrolyte (especially sodium and chloride) and water movement into the lumen. Dysfunctional ion channels play a key role in the development of diarrhea. Infectious pathogens, including Salmonella spp. and C. difficile, have been shown to regulate ion channels in a variety of ways. In other species, there has been an increased interest in ion channel manipulation as an anti-diarrheal treatment. While targeting ion channels also represents a promising way to manage diarrhea associated with equine colitis, ion channels have not been well studied in the equine colon. This review provides an overview of what is known about colonic ion channels and their known or putative role in specific types of equine colitis due to various pathogens.
- Open Access
Single Cell Analysis Reveals Multi-faceted miR-375 Regulation of the Intestinal Crypt
Summary: The role of individual miRNAs in small intestinal (SI) epithelial homeostasis is under-explored. In this study, we discovered that miR-375 is among the most enriched miRNAs in intestinal crypts and stem cells (ISCs), especially facultative ISCs. We then showed by multiple manipulations, including CRISPR/Cas9 editing, that miR-375 is strongly suppressed by Wnt-signaling. Single-cell RNA-seq analysis of SI crypt-enriched cells from miR-375 knockout (375-KO) mice revealed elevated numbers of tuft cells and increased expression of pro-proliferative genes in ISCs. Accordingly, the genetic loss of miR-375 promoted resistance to helminth infection and enhanced the regenerative response to irradiation. The conserved effects of miR-375 were confirmed by gain-of-function studies in Drosophila midgut stem cells in vivo. Moreover, functional experiments in enteroids uncovered a regulatory relationship between miR-375 and Yap1 that controls cell survival. Finally, analysis of mouse model and clinical data revealed an inverse association between miR-375 levels and intestinal tumor development. Highlights: miR-375 is one of the most enriched miRNAs in ISCs, especially facultative ISCs. miR-375 modifies tuft cell abundance and pro-proliferative gene expression in ISCs. Loss of miR-375 in mice enhances the host response to helminth infection and crypt regeneration. Mouse and human intestinal cancer are associated with reduced miR-375 expression. eTOC Blurb: Sethupathy and colleagues show that miR-375 is a Wnt-responsive, ISC-enriched miRNA that serves as a break on intestinal crypt proliferation. They also show that miR-375 modulates tuft cell abundance and pro-proliferative gene expression in ISCs, that miR-375 loss enhances the host response to helminth infection as well as crypt regeneration post-irradiation, and its reduced expression is associated with intestinal cancer.
Open AccessSingle Cell Analysis Reveals Multi-faceted miR-375 Regulation of the Intestinal Crypt
Summary: The role of individual miRNAs in small intestinal (SI) epithelial homeostasis is under-explored. In this study, we discovered that miR-375 is among the most enriched miRNAs in intestinal crypts and stem cells (ISCs), especially facultative ISCs. We then showed by multiple manipulations, including CRISPR/Cas9 editing, that miR-375 is strongly suppressed by Wnt-signaling. Single-cell RNA-seq analysis of SI crypt-enriched cells from miR-375 knockout (375-KO) mice revealed elevated numbers of tuft cells and increased expression of pro-proliferative genes in ISCs. Accordingly, the genetic loss of miR-375 promoted resistance to helminth infection and enhanced the regenerative response to irradiation. The conserved effects of miR-375 were confirmed by gain-of-function studies in Drosophila midgut stem cells in vivo. Moreover, functional experiments in enteroids uncovered a regulatory relationship between miR-375 and Yap1 that controls cell survival. Finally, analysis of mouse model and clinical data revealed an inverse association between miR-375 levels and intestinal tumor development. Highlights: miR-375 is one of the most enriched miRNAs in ISCs, especially facultative ISCs. miR-375 modifies tuft cell abundance and pro-proliferative gene expression in ISCs. Loss of miR-375 in mice enhances the host response to helminth infection and crypt regeneration. Mouse and human intestinal cancer are associated with reduced miR-375 expression. eTOC Blurb: Sethupathy and colleagues show that miR-375 is a Wnt-responsive, ISC-enriched miRNA that serves as a break on intestinal crypt proliferation. They also show that miR-375 modulates tuft cell abundance and pro-proliferative gene expression in ISCs, that miR-375 loss enhances the host response to helminth infection as well as crypt regeneration post-irradiation, and its reduced expression is associated with intestinal cancer.
- Open Access
- 1 January 2020
- Published by Elsevier in SSRN Electronic Journal
Epithelial Regeneration after Doxorubicin Arises Primarily from Early Progeny of Active Intestinal Stem Cells
Active intestinal stem cells (aISCs) are sensitive to acute insults such as chemotherapy and irradiation. The epithelium is highly plastic, with multiple cell populations possessing regenerative capacity after aISC depletion. However the cellular origin of epithelial regeneration after doxorubicin is poorly understood. Here, we show that regeneration after doxorubicin primarily arises from early progeny – transit amplifying cells produced by aISCs less than 24 hours prior to damage. Early progeny cells were not quiescent, suggesting other mechanisms for chemoresistance. Early progeny cells expressed lower levels of Top2a and homologous recombination transcripts compared to aISCs, which may decrease chemosensitivity. After doxorubicin, these cells increase stem cell transcript expression, consistent with their regenerative capacity. Although aISC depletion was similar, irradiation-induced regeneration does not rely on early progeny cells. We show that doxorubicin effectively depletes aISCs in the small intestine and subsequent intestinal regeneration is dependent on early progeny cells.
- 1 January 2020
- Published by Elsevier in SSRN Electronic Journal
Open AccessEpithelial Regeneration after Doxorubicin Arises Primarily from Early Progeny of Active Intestinal Stem Cells
Active intestinal stem cells (aISCs) are sensitive to acute insults such as chemotherapy and irradiation. The epithelium is highly plastic, with multiple cell populations possessing regenerative capacity after aISC depletion. However the cellular origin of epithelial regeneration after doxorubicin is poorly understood. Here, we show that regeneration after doxorubicin primarily arises from early progeny – transit amplifying cells produced by aISCs less than 24 hours prior to damage. Early progeny cells were not quiescent, suggesting other mechanisms for chemoresistance. Early progeny cells expressed lower levels of Top2a and homologous recombination transcripts compared to aISCs, which may decrease chemosensitivity. After doxorubicin, these cells increase stem cell transcript expression, consistent with their regenerative capacity. Although aISC depletion was similar, irradiation-induced regeneration does not rely on early progeny cells. We show that doxorubicin effectively depletes aISCs in the small intestine and subsequent intestinal regeneration is dependent on early progeny cells.
- Open Access
- 1 January 2019
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 8 (4) , 549-560
Mist1 Expression Is Required for Paneth Cell Maturation
- 1 January 2019
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 8 (4) , 549-560
Open AccessMist1 Expression Is Required for Paneth Cell Maturation